NO953281D0 - Use of oligosaccharide glycosides as inhibitors of bacterial adherence - Google Patents

Use of oligosaccharide glycosides as inhibitors of bacterial adherence

Info

Publication number: NO953281D0
Authority: NO; Norway
Prior art keywords: inhibitors; bacterial adherence; oligosaccharide glycosides; glycosides; oligosaccharide
Prior art date: 1993-02-26

Application number

NO953281A

Other languages

Norwegian (no)

Other versions

NO953281L (en

Inventor

Jan Staffan Normark

Per Falk

Thomas Boren

Original Assignee

Jan Staffan Normark

Per Falk

Thomas Boren

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-26

Filing date

1995-08-21

Publication date

1995-08-21

1993-02-26 Priority claimed from DK22293A external-priority patent/DK22293D0/en

1993-06-25 Priority claimed from DK76093A external-priority patent/DK76093D0/en

1995-08-21 Application filed by Jan Staffan Normark, Per Falk, Thomas Boren filed Critical Jan Staffan Normark

1995-08-21 Publication of NO953281D0 publication Critical patent/NO953281D0/en

1995-08-21 Publication of NO953281L publication Critical patent/NO953281L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Marine Sciences & Fisheries (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

NO953281A 1993-02-26 1995-08-21 Use of oligosaccharide glycosides as inhibitors of bacterial adherence NO953281L (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DK22293A DK22293D0 (en)	1993-02-26	1993-02-26	USE OF GLYCOSIDES
DK76093A DK76093D0 (en)	1993-06-25	1993-06-25	USE OF GLYCOSIDES
PCT/IB1994/000023 WO1994018986A1 (en)	1993-02-26	1994-02-25	Use of oligosaccharide glycosides as inhibitors of bacterial adherence

Publications (2)

Publication Number	Publication Date
NO953281D0 true NO953281D0 (en)	1995-08-21
NO953281L NO953281L (en)	1995-08-21

Family

ID=26063555

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO953281A NO953281L (en)	1993-02-26	1995-08-21	Use of oligosaccharide glycosides as inhibitors of bacterial adherence

Country Status (8)

Country	Link
EP (1)	EP0690717A1 (en)
JP (1)	JPH08509467A (en)
CN (1)	CN1121311A (en)
AU (1)	AU6042594A (en)
CA (1)	CA2157049A1 (en)
HU (1)	HU9502497D0 (en)
NO (1)	NO953281L (en)
WO (1)	WO1994018986A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6204431B1 (en)	1994-03-09	2001-03-20	Abbott Laboratories	Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
DE19701382A1 (en) *	1997-01-16	1998-07-23	Nutricia Nv	Carbohydrate mix
KR100460173B1 (en) *	1998-12-11	2004-12-04	겐 코오포레이션	Inhibitor of helicobacter pylori colonization
PT1255449E (en) *	2000-02-17	2007-08-24	Wyeth Corp	Nutritional formulation containing prebiotic substances
US6630452B2 (en)	2000-02-17	2003-10-07	Wyeth	Nutritional formulation containing prebiotic substances
ATE429233T1 (en) *	2001-06-29	2009-05-15	Glykos Finland Oy	USE OF AT LEAST ONE GLYCOINHIBITOR SUBSTANCE AGAINST INFECTIOUS DISEASES
DE10147100A1 (en) *	2001-09-25	2003-04-17	Numico Res B V	Anti-infective carbohydrates
AU2003270619A1 (en)	2002-09-12	2004-04-30	Molecular Probes, Inc.	Site-specific labeling of affinity tags in fusion proteins
EP2631650B1 (en)	2007-09-07	2015-04-22	Children's Hospital Medical Center	Composition comprising alpha-1,2 fucosyl glycans for treating gastrointestinal disorders
RU2410100C2 (en) *	2009-03-30	2011-01-27	Александр Владимирович Диковский	Pharmaceutical composition of proton pump inhibitor and prebiotic for treating gastric and duodenal ulcers
EP3248605A1 (en)	2009-07-06	2017-11-29	Children's Hospital Medical Center	Inhibiting inflammation with milk oligosaccharides
CN108741083A (en) *	2010-12-31	2018-11-06	雅培制药有限公司	Promote the neutral human milk oligosaccharides of beneficial bacteria growth
EP2692740A1 (en) *	2012-07-30	2014-02-05	Le Centre National De La Recherche Scientifique	Glycan compositions, processes for preparing the same and their uses as a drug
WO2014130789A1 (en)	2013-02-21	2014-08-28	Children's Hospital Medical Center	Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
US10857167B2 (en)	2015-04-28	2020-12-08	Children's Hospital Medical Center	Use of oligosaccharide compositions to enhance weight gain
CN111436617B (en) *	2020-05-12	2022-12-23	西北大学	Application and preparation method of fucose pseudoglycoprotein based on bovine serum albumin in inhibiting inert agglutinating bacteria

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4935406A (en) *	1988-09-20	1990-06-19	Marion Laboratories, Inc.	Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
US5116821A (en) *	1990-11-20	1992-05-26	The Procter & Gamble Company	Sulfated glyceroglucolipids as inhibitors of bacterial adherence
AU4993893A (en) *	1992-07-31	1994-03-03	Neose Pharmaceuticals, Inc.	Compositions for treating and inhibiting gastric and duodenal ulcers

1994
- 1994-02-25 CN CN94191793A patent/CN1121311A/en active Pending
- 1994-02-25 AU AU60425/94A patent/AU6042594A/en not_active Abandoned
- 1994-02-25 CA CA002157049A patent/CA2157049A1/en not_active Abandoned
- 1994-02-25 WO PCT/IB1994/000023 patent/WO1994018986A1/en not_active Application Discontinuation
- 1994-02-25 HU HU9502497A patent/HU9502497D0/en unknown
- 1994-02-25 JP JP6518792A patent/JPH08509467A/en active Pending
- 1994-02-25 EP EP94906981A patent/EP0690717A1/en not_active Withdrawn
1995
- 1995-08-21 NO NO953281A patent/NO953281L/en unknown

Also Published As

Publication number	Publication date
EP0690717A1 (en)	1996-01-10
JPH08509467A (en)	1996-10-08
CN1121311A (en)	1996-04-24
CA2157049A1 (en)	1994-09-01
WO1994018986A1 (en)	1994-09-01
AU6042594A (en)	1994-09-14
NO953281L (en)	1995-08-21
HU9502497D0 (en)	1995-10-30

Publication	Publication Date	Title
NO953281D0 (en)	1995-08-21	Use of oligosaccharide glycosides as inhibitors of bacterial adherence
IL110074A0 (en)	1994-10-07	Fucosylated glycosides as inhibitors of bacterial adherence
NO980467L (en)	1998-04-03	4-mercaptopyrrolidine derivatives as farnesyl transerase inhibitors
DE69431478D1 (en)	2002-11-07	MEDICAL DISTRIBUTOR ACTIVATED BY VACUUM
DE69429102D1 (en)	2001-12-20	ACOUSTIC VIRTUAL ENVIRONMENT
NO975740L (en)	1998-01-26	Arylsulfonylaminobenzene derivatives and their use as factor Xa inhibitors
AU5326296A (en)	1996-10-16	Substituted benzene derivatives useful as neuraminidase inhi bitors
NO944919D0 (en)	1994-12-19	Method of inhibiting atrophy of the skin or vagina
AU635415B2 (en)	1993-03-18	Use of n-alkyl-lactams as crystallization inhibitors
FI973211A0 (en)	1997-08-01	Proline derivatives useful as human leukocyte elastase inhibitors
LV11475A (en)	1996-08-20	Cryostanic monohydrate of spirostanil glycoside
DK0842185T3 (en)	2002-02-04	Ara-C derivatives
AU2831992A (en)	1993-05-13	Skin cleansing compositions
FI944280A0 (en)	1994-09-15	Cyclobutenedione derivatives of indolylalkyl-pyridinyl- and pyrimidinyl-piperazines against mingrene
DE69616554D1 (en)	2001-12-06	SIALIC ACID DERIVATIVES
BR9609723A (en)	1999-03-16	Derivatives of tricetone
FI973277A0 (en)	1997-08-08	Pharmaceutical preparations for the inhibition of TNF
AU2214195A (en)	1995-10-17	Injectable solutions of dirithromycin
KR940003955U (en)	1994-02-21	Rear spacer of refrigerator
FI942238A0 (en)	1994-05-13	Asymmetric hydrogenation of furoimidazole derivatives
KR970019040U (en)	1997-05-26	Shelf of refrigerator
KR970046689U (en)	1997-07-31	Backplane Structure of Sputtering Device
KR970024916U (en)	1997-06-20	Refrigerator consisting of tempered glass shelves
KR960015197U (en)	1996-05-17	Rear structure of small refrigerator
KR950005538U (en)	1995-03-20	Sanitary cutlery